RTTNews) – Biogen Inc. (BIIB) said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA adopted a positive opinion for Tofidence (tocilizumab), a biosimilar monoclonal antibody referencing Roactemra… Read More
